Aarti Drugs Limited (AARTIDRUGS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.104x

Based on the latest financial reports, Aarti Drugs Limited (AARTIDRUGS) has a cash flow conversion efficiency ratio of 0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.52 Billion ≈ $16.48 Million USD) by net assets (Rs14.69 Billion ≈ $158.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AARTIDRUGS stock market capitalisation for the company's overall valuation and market capitalisation.

Aarti Drugs Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aarti Drugs Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aarti Drugs Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aarti Drugs Limited ranked by their cash flow conversion efficiency. Explore Aarti Drugs Limited earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Multiconsult AS OL:MULTI	0.212x
Zhongxing Shenyang Commercial Building Group Co Ltd SHE:000715	0.029x
Nanning Department Store Co Ltd SHG:600712	0.000x
ZheJiang Haers Vacuum Containers Co Ltd SHE:002615	0.076x
Lets Holding Group Co Ltd SHE:002398	0.022x
Hibiscus Petroleum BHD KLSE:5199	-0.186x
YTL Hospitality REIT KLSE:5109	0.012x
Belo Sun Mining Corp. TO:BSX	-0.161x

Annual Cash Flow Conversion Efficiency for Aarti Drugs Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aarti Drugs Limited from 2007 to 2025. View AARTIDRUGS share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs13.69 Billion ≈ $148.09 Million	Rs2.45 Billion ≈ $26.45 Million	0.179x	-36.21%
2024-03-31	Rs12.82 Billion ≈ $138.64 Million	Rs3.59 Billion ≈ $38.82 Million	0.280x	+148.83%
2023-03-31	Rs11.93 Billion ≈ $128.98 Million	Rs1.34 Billion ≈ $14.51 Million	0.113x	+67.45%
2022-03-31	Rs10.36 Billion ≈ $112.07 Million	Rs696.36 Million ≈ $7.53 Million	0.067x	-60.36%
2021-03-31	Rs9.13 Billion ≈ $98.78 Million	Rs1.55 Billion ≈ $16.75 Million	0.170x	-55.88%
2020-03-31	Rs6.52 Billion ≈ $70.56 Million	Rs2.51 Billion ≈ $27.12 Million	0.384x	+45.95%
2019-03-31	Rs5.43 Billion ≈ $58.77 Million	Rs1.43 Billion ≈ $15.47 Million	0.263x	+71.88%
2018-03-31	Rs4.55 Billion ≈ $49.25 Million	Rs697.66 Million ≈ $7.54 Million	0.153x	-63.96%
2017-03-31	Rs4.11 Billion ≈ $44.42 Million	Rs1.75 Billion ≈ $18.88 Million	0.425x	+13.96%
2016-03-31	Rs3.57 Billion ≈ $38.65 Million	Rs1.33 Billion ≈ $14.42 Million	0.373x	+9.88%
2015-03-31	Rs3.08 Billion ≈ $33.33 Million	Rs1.05 Billion ≈ $11.31 Million	0.339x	-10.76%
2014-03-31	Rs2.51 Billion ≈ $27.13 Million	Rs954.26 Million ≈ $10.32 Million	0.380x	+6.26%
2013-03-31	Rs2.08 Billion ≈ $22.45 Million	Rs743.10 Million ≈ $8.04 Million	0.358x	+72.40%
2012-03-31	Rs1.76 Billion ≈ $19.09 Million	Rs366.41 Million ≈ $3.96 Million	0.208x	+64.76%
2011-03-31	Rs1.63 Billion ≈ $17.65 Million	Rs205.60 Million ≈ $2.22 Million	0.126x	-68.79%
2010-03-31	Rs1.46 Billion ≈ $15.84 Million	Rs591.20 Million ≈ $6.39 Million	0.404x	-18.58%
2009-03-31	Rs1.23 Billion ≈ $13.35 Million	Rs612.10 Million ≈ $6.62 Million	0.496x	+94.81%
2008-03-31	Rs1.12 Billion ≈ $12.06 Million	Rs283.87 Million ≈ $3.07 Million	0.255x	-12.94%
2007-03-31	Rs1.00 Billion ≈ $10.83 Million	Rs292.69 Million ≈ $3.17 Million	0.292x	--

About Aarti Drugs Limited

NSE:AARTIDRUGS India Drug Manufacturers - Specialty & Generic

Market Cap

$426.21 Million

Rs39.41 Billion INR

Market Cap Rank

#13191 Global

#652 in India

Share Price

Rs431.80

Change (1 day)

+0.81%

52-Week Range

Rs319.75 - Rs524.60

All Time High

Rs1001.57